A randomised single blind standard controlled phase 2 trial of adjunctive ibuprofen for pulmonary tuberculous in Adults

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800016451

Enrollment

Unknown

Registered

2018-06-02

Start date

2018-08-01

Completion date

Unknown

Last updated

2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary tuberculosis

Interventions

control group:standard anti-TB regimen

treatment group:standard anti-TB regimen and ibuprofen

Eligibility

Sex/Gender

All

Age

16 Years to 70 Years

Inclusion criteria

Inclusion criteria: sputum smear-positive pulmonary tuberculosis patients.

Exclusion criteria

Exclusion criteria: 1. aged<16 and =70 years; 2. tuberculous meningitis or tuberculous pleurisy who require hormone; 3. combined with diabetes; 4. pregnant or lactating women; 5. digestive tract ulcers; 6. organ failure (the heart,liver,lungs,and kidneys); 7. a long history of exposure to dust and pneumoconiosis annot be excluded; 8. a history of intravenous drug; 9. HIV-positive; 10. TPPA-positive; 11. refused to participate.

Design outcomes

Primary

Measure	Time frame
sputum mycobacterial load;	—

Secondary

Measure	Time frame
Chest CT;prostaglandin H2;	—

Countries

China

Contacts

Public ContactLi Kui

Ankang Central Hospital of Shaanxi Province

42131642@qq.com+86 13571422201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026